Cancer - Two in one

被引：8

作者：

Berns, A

机构：

[1] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands

[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands

来源：

NATURE | 2005年 / 436卷 / 7052期

关键词：

D O I：

10.1038/436787a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

As cancer develops, at least two cell processes are disrupted — cell growth is promoted, and cell death inhibited. It seems that mutated versions of the notorious cancer-promoting protein MYC can accomplish both at once.

引用

页码：787 / +

页数：2

共 7 条

[1] The c-myc transactivation domain is a direct modulator of apoptotic versus proliferative signals [J].

Chang, DW ;

Claassen, GF ;

Hann, SR ;

Cole, MD .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4309-4319

[2] G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression [J].

Collins, NL ;

Reginato, MJ ;

Paulus, JK ;

Sgroi, DC ;

LaBaer, J ;

Brugge, JS .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (12) :5282-5291

[3] Bim is a suppressor of Myc-induced mouse B cell leukemia [J].

Egle, A ;

Harris, AW ;

Bouillet, P ;

Cory, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6164-6169

[4] Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants [J].

Hemann, MT ;

Bric, A ;

Teruya-Feldstein, J ;

Herbst, A ;

Nilsson, JA ;

Cordon-Cardo, C ;

Cleveland, JL ;

Tansey, WP ;

Lowe, SW .

NATURE, 2005, 436 (7052) :807-811

[5] A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy [J].

Schmitt, CA ;

Fridman, JS ;

Yang, M ;

Lee, S ;

Baranov, E ;

Hoffman, RM ;

Lowe, SW .

CELL, 2002, 109 (03) :335-346

[6] Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage [J].

Seoane, J ;

Le, HV ;

Massagué, J .

NATURE, 2002, 419 (6908) :729-734

[7] Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter [J].

Wu, SQ ;

Cetinkaya, C ;

Munoz-Alonso, MJ ;

von der Lehr, N ;

Bahram, F ;

Beuger, V ;

Eilers, M ;

Leon, J ;

Larsson, LG .

ONCOGENE, 2003, 22 (03) :351-360

← 1 →